Search results
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 7 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 3 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
Analysis | Court rejects abortion pill challenge, but what happens next?
Washington Post· 7 days agoWhat do you think is next in the fight over medication abortion? Today’s edition: Senate Republicans...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 6 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain of the JN.1 variant ...
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day...
Benzinga· 3 days agoShares of Quantum Corporation QMCO fell sharply during Tuesday's session after the company reported...